<PAGE> 1
October 24, 2000
VIA EDGAR AND FACSIMILE
Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Washington, D.C. 20549
Re: MD2patient, Inc. Registration Statement on Form S-1
(Reg. No. 333-91619)
Ladies and Gentlemen:
Pursuant to Rule 477 under the Securities Act of 1933, as amended, the
undersigned registrant, MD2patient, Inc. (the "Company"), hereby requests the
Commission's consent to withdraw the above-referenced Registration Statement.
In light of current market conditions, the Company has determined not
to proceed with the public offering contemplated by the Registration Statement
at this time. No securities have been sold pursuant to the offering and, in
accordance with the terms of the offering, the Company will return the payments
for shares currently held in escrow.
The Company believes that withdrawal of the Registration Statement is
consistent with the public interest and the protection of investors.
Accordingly, the Company respectfully requests that the Commission grant its
request to withdraw the Registration Statement.
If you have questions or comments about the foregoing, please call me
at (615) 383-8400 or J. Mark Ray of Alston & Bird LLP at (404) 881-7739.
Sincerely,
/s/ James G. Petway, Jr.
James G. Petway, Jr.
cc: J. Mark Ray, Esq.
